These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6876750)

  • 21. Assessment of self administration of dapsone in urine by out-patients attending field clinics.
    Balakrishnan S; Christian M
    Lepr India; 1980 Apr; 52(2):249-51. PubMed ID: 7453139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 23. Regularity of dapsone intake by leprosy patients attending urban treatment centre.
    Naik SS; Ganapati R
    Lepr India; 1977 Apr; 49(2):207-15. PubMed ID: 909287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Suspicion of paucibacillary leprosy resistant to dapsone: importance of follow-up].
    Husser JA; Pattyn SR
    Acta Leprol; 1987; 5(2):147-50. PubMed ID: 3303807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Absenteeism during treatment for leprosy. Analysis of causes as apparent from a survey in southern India].
    Vellut C; Van der Veid D; Supplisson C; Decazes JM
    Acta Leprol; 1982; (89):27-38. PubMed ID: 6819753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follow-up of lepromatous (LL and BL) patients on dapsone (DDS) monotherapy after attainment of smear negativity in Gudiyatham Taluk, South India.
    Almeida JG; Christian M; Chacko CJ
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):382-4. PubMed ID: 6685702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug compliance among self-motivated leprosy patients.
    Girdhar A; Mishra B; Bagga A; Girdhar BK
    Indian J Lepr; 1988 Oct; 60(4):506-9. PubMed ID: 3253330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of "tile reaction" test for screening dapsone in urine.
    Irudaya Raj PP; Lilly L; Aschhoff M; Balakrishnan S
    Lepr India; 1983 Oct; 55(4):654-64. PubMed ID: 6668921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dapsone compliance in an urban field project.
    Revankar CR; Naik SS; Ganapati R
    Lepr India; 1983 Jan; 55(1):117-21. PubMed ID: 6876753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lagophthalmos and posterior synechiae of the iris during treatment of leprosy with diaminodiphenylsulfone].
    Brandt F; Adiga RB; Pradhan H
    Klin Monbl Augenheilkd; 1984 Jan; 184(1):28-31. PubMed ID: 6708382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical diagnosis of dapsone resistant leprosy.
    Taylor PM
    Lepr India; 1982 Jan; 54(1):117-22. PubMed ID: 7047897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vitamin E as protective agent against hemolysis in leprosy patients under dapsone treatment].
    Lardo MM; Díaz NB; Artaza JR; Carbia CD; Nazer R; Valdez R
    Medicina (B Aires); 1997; 57(2):150-4. PubMed ID: 9532824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Various psychosocial and epidemiologic characteristics of leprosy in the Artemisa municipality].
    de Rojas y López del Rincón V; Garcia S; Mijail Díaz J
    Rev Cubana Med Trop; 1990; 42(1):53-68. PubMed ID: 2259782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary dapsone-resistant leprosy in Cebu, Philippines.
    Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leprosy disease in Nepal : knowledge and non-compliance of patients.
    Chalise SC
    JNMA J Nepal Med Assoc; 2005; 44(158):39-43. PubMed ID: 16554869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spot test for detection of dapsone in urine: an assessment of its validity and interpretation in monitoring dapsone self-administration.
    Huikeshoven H; Madarang MG
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):21-4. PubMed ID: 3711714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
    Paul S; Rose ET
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
    [No Abstract]   [Full Text] [Related]  

  • 40. Absenteeism in leprosy patients in a rural area in Tamil Nadu.
    Raghavia M; Bansal RD; Srinivasa DK; Soudarssanane MB; Ramana G
    Indian J Lepr; 1987; 59(3):322-9. PubMed ID: 3440852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.